°®¶¹´«Ã½

The 2024 ASM Clinical Virology Symposium (CVS) will have nearly 30 companies presenting their latest products from across the microbial sciences. ASM CVS's Industry & Science programming is sponsored by our 2024 exhibitors and offers 3 presentations on cutting-edge microbiological innovations. These sessions are free to ASM CVS attendees and provide a unique opportunity for attendees to engage in new product development and discover the latest technologies and innovations on the market. Presentations will kick off on Tuesday, Oct. 8, with free Industry & Science workshops, and continue through Wednesday, Oct.9.

All Industry and Science Programming will take place in the Exhibit Hall Theater at the designated times below.

Tuesday, Oct. 8, 10:15 a.m. PT

Supported by QIAGEN

Detecting parecho- and enterovirus pathogens in cerebrospinal fluid (CSF) presents a significant diagnostic challenge due to the need for high sensitivity and accuracy. In this talk, the team from Children’s Mercy Hospital will share how absolute quantification with digital PCR (dPCR) enables sensitive and accurate detection of parecho- and enterovirus pathogens in CSF using the QIAcuity system from QIAGEN. During the talk, you’ll learn about 3 key areas: the value of dPCR for pathogen detection, performance validation data (sensitivity, specificity, dynamic range, LOD and LOQ), and a simplified workflow. By leveraging the precision and reliability of dPCR, this approach offers a robust solution for improving pathogen detection in clinical settings.

Speakers:

• Rangaraj Selvarangan, Ph.D., D(ABMM), FIDSA, FAAM,Director Clinical °®¶¹´«Ã½ and Molecular Infectious Diseases Lab,Children’s Mercy Hospital, Kansas City.
• Anjana Sasidharan, M.S., MB(ASCP)CM, Supervisor Laboratory Medicine Research, Children’s Mercy Hospital, Kansas City.
• Debarpan Dhar, Ph.D., M.S.,Postdoctoral Research Scholar, Children’s Mercy Hospital, Kansas City.

Tuesday, Oct. 8, 11:15 a.m. PT

Supported by Copan

Join Susan Sharp, Ph.D., as she explains the operation of this unique liquid handling system and its applications. This cutting-edge liquid handling system revolutionizes specimen preparation for crucial tests, including upper respiratory tract viral molecular testing, STI molecular diagnosis, QuantiFERON testing for TB exposure and cervical cancer screening using HPV molecular testing. Sharp will explore how UniVerse® optimizes workflow, ensures traceability, enhances testing quality and reduces costs. Whether you’re a lab technician, manager or scientist, this talk will offer valuable strategies to elevate your lab’s efficiency and performance.

Speaker:

• Susan Sharp, Ph.D., D(ABMM), FAAM, Scientific Director, Copan Diagnostics; Diplomate, American Board of Medical °®¶¹´«Ã½; Fellow, American Academy of °®¶¹´«Ã½; Past-President, ASM; Board of Governors, AAM.

Wednesday, Oct. 9, 10:15 a.m. PT

Supported by QIAGEN
Scope: U.S.

Overlapping symptoms can be a challenge to diagnose and treat. Additional patient factors compound this complexity, such as the underlying patient pathology, comorbidities, symptom severity and risk profile. As a result, providers may have difficulty choosing an appropriate treatment plan for an individual patient’s disease. 

During this workshop, Nathan A. Ledeboer, Ph.D., will discuss the importance of patient profiling in the diagnostic process, focusing on syndromic testing with expanded panels. He will explore how crucial this approach is for accurately selecting the right syndromic test for the right patient, including in the context of the current reimbursement landscape. 

By choosing the correct test, providers can optimize their treatment plan based on revealed positive (or negative) results. Not every patient requires a high-plex test. On the other hand, some who receive a low-plex test require an expanded panel to ensure a less-common positive result is not overlooked. This workshop will clarify the complexities of expanded panel testing versus low-plex and more targeted testing in the context of the "right test for the right patient at the right time."

Speaker:

• Nathan A. Ledeboer, Ph.D., Professor and Vice Chair of Pathology, Medical College of Wisconsin.